Kieron Jones
CEO of K2bio
About K2bio
A hybrid CRO scaling the peaks of biopharma research
K2bio is a hybrid Contract Research Organization (CRO) enabling early-stage life science companies to develop the next generation of innovative therapies.
Our mission is to provide comprehensive help and support along the way.
We offer a state-of-the-art facility with experienced research managers and staff and an on-site vivarium. Our mix of private and shared research laboratory space offers affordable access for early-stage biopharmaceutical companies. In addition, our team provides guidance and phase-appropriate regulatory oversight throughout the product research and development lifecycle.
Simply put, we handle the business end of projects while our partners focus on what is most important: science.
It’s been a long-time dream of mine to scale the highest peaks of K2, the most technically challenging mountain climb in the world. While a treacherous journey, I can imagine no more extraordinary view than that from the top. Biopharmaceutical research is much like scaling K2—complex, challenging, and well worth the climb.
It’s been a long-time dream of mine to scale the highest peaks of K2, the most technically challenging mountain climb in the world. While a treacherous journey, I can imagine no more extraordinary view than that from the top. Biopharmaceutical research is much like scaling K2—complex, challenging, and well worth the climb.
Kieron Jones
CEO of K2bio
